Literature DB >> 21511746

Fulminant myocarditis owing to high-dose interleukin-2 therapy for metastatic melanoma.

P Thavendiranathan1, D Verhaert, K L Kendra, S V Raman.   

Abstract

High-dose interleukin-2 (IL-2) therapy may cause acute myocarditis characterised by diffuse myocardial involvement and occasionally fulminant heart failure. Cardiac MRI (CMRI) provides a comprehensive assessment of myocardial function, inflammation and injury in a single examination and has shown value in the diagnosis of myocarditis. We report a case of a 54-year-old male with metastatic melanoma who developed acute severe myocarditis with fulminant heart failure after high-dose IL-2 therapy. CMRI using a combination of T(2) weighted imaging and T(1) weighted late post-gadolinium enhancement techniques played a key role in establishing the diagnosis. To our knowledge we present the first case report of the combined use of T(1) and T(2) weighted CMRI techniques to diagnose IL-2 induced myocarditis.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21511746      PMCID： PMC3473643          DOI： 10.1259/bjr/13448473

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  9 in total

1.  The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology.

Authors:  Leslie T Cooper; Kenneth L Baughman; Arthur M Feldman; Andrea Frustaci; Mariell Jessup; Uwe Kuhl; Glenn N Levine; Jagat Narula; Randall C Starling; Jeffrey Towbin; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2007-11-06       Impact factor: 24.094

Review 2.  T2-weighted cardiovascular magnetic resonance imaging.

Authors:  Hassan Abdel-Aty; Orlando Simonetti; Matthias G Friedrich
Journal:  J Magn Reson Imaging       Date:  2007-09       Impact factor: 4.813

3.  High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update.

Authors:  M B Atkins; L Kunkel; M Sznol; S A Rosenberg
Journal:  Cancer J Sci Am       Date:  2000-02

4.  Myocarditis. A histopathologic definition and classification.

Authors:  H T Aretz; M E Billingham; W D Edwards; S M Factor; J T Fallon; J J Fenoglio; E G Olsen; F J Schoen
Journal:  Am J Cardiovasc Pathol       Date:  1987-01

Review 5.  Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications.

Authors:  Han W Kim; Afshin Farzaneh-Far; Raymond J Kim
Journal:  J Am Coll Cardiol       Date:  2009-12-29       Impact factor: 24.094

Review 6.  Case report and brief review: IL-2-induced myocarditis.

Authors:  Robert M Eisner; Aliya Husain; Joseph I Clark
Journal:  Cancer Invest       Date:  2004       Impact factor: 2.176

Review 7.  Myocarditis.

Authors:  Leslie T Cooper
Journal:  N Engl J Med       Date:  2009-04-09       Impact factor: 91.245

8.  Cardiotoxicity of human recombinant interleukin-2 in rats. A morphological study.

Authors:  J Zhang; Z X Yu; S L Hilbert; M Yamaguchi; D P Chadwick; E H Herman; V J Ferrans
Journal:  Circulation       Date:  1993-04       Impact factor: 29.690

9.  Cardiovascular magnetic resonance in myocarditis: A JACC White Paper.

Authors:  Matthias G Friedrich; Udo Sechtem; Jeanette Schulz-Menger; Godtfred Holmvang; Pauline Alakija; Leslie T Cooper; James A White; Hassan Abdel-Aty; Matthias Gutberlet; Sanjay Prasad; Anthony Aletras; Jean-Pierre Laissy; Ian Paterson; Neil G Filipchuk; Andreas Kumar; Matthias Pauschinger; Peter Liu
Journal:  J Am Coll Cardiol       Date:  2009-04-28       Impact factor: 24.094
  9 in total
  7 in total

1.  When Lightning Strikes: Fulminant Myocarditis in the Realm of Inflammatory Cardiomyopathies.

Authors:  Leslie T Cooper
Journal:  Circulation       Date:  2017-08-08       Impact factor: 29.690

Review 2.  Cardiotoxicity of Systemic Melanoma Treatments.

Authors:  Neha Mukunda; Srilakshmi Vallabhaneni; Benedicte Lefebvre; Michael G Fradley
Journal:  Curr Treat Options Oncol       Date:  2022-02-22

Review 3.  Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth.

Authors:  Nathan A Holland; Jake T Francisco; Sean C Johnson; Joshua S Morgan; Troy J Dennis; Nishitha R Gadireddy; David A Tulis
Journal:  J Cardiovasc Dev Dis       Date:  2018-01-23

Review 4.  Side effects of cytokines approved for therapy.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2014-11       Impact factor: 5.606

Review 5.  SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients.

Authors:  Vincenzo Quagliariello; Annamaria Bonelli; Antonietta Caronna; Gabriele Conforti; Martina Iovine; Andreina Carbone; Massimiliano Berretta; Gerardo Botti; Nicola Maurea
Journal:  Cancers (Basel)       Date:  2020-11-10       Impact factor: 6.639

6.  Suppression of Inflammatory Cardiac Cytokine Network in Rats with Untreated Obesity and Pre-Diabetes by AT2 Receptor Agonist NP-6A4.

Authors:  Madhavi P Gavini; Abuzar Mahmood; Anthony M Belenchia; Paige Beauparlant; Senthil A Kumar; Sivakumar Ardhanari; Vincent G DeMarco; Lakshmi Pulakat
Journal:  Front Pharmacol       Date:  2021-06-18       Impact factor: 5.810

7.  A Case of Myocarditis and Near-Lethal Arrhythmia Associated With Interleukin-2 Therapy.

Authors:  Stephanie Wu; Anna Sarcon; Khuyen Do; Jerold Shinbane; Rahul Doshi; Helga Van Herle
Journal:  J Investig Med High Impact Case Rep       Date:  2018-01-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.